Literature DB >> 16688922

Impact of pay-for-performance contracts and network registry on diabetes and asthma HEDIS measures in an integrated delivery network.

Jeffrey Levin-Scherz1, Nicole DeVita, Justin Timbie.   

Abstract

This article reviews the experience of a large, heterogeneous integrated delivery network that incorporated physician quality metrics into pay-for-performance contracts. The authors present criteria for including measures in pay-for-performance contracts and offer a practical approach to determining withhold return or bonus distribution based on improvement and performance. They demonstrate interventions undertaken to improve performance, including the development of a claims-based registry. Empirical data show that the network performance improved more than the comparable state and national performance during the period of this observational study. The authors conclude that pay-for-performance contracts led to development of medical management programs including a claims-based registry and nonphysician interventions, which helped significantly improve selected HEDIS scores.

Entities:  

Mesh:

Year:  2006        PMID: 16688922     DOI: 10.1177/1077558705284057

Source DB:  PubMed          Journal:  Med Care Res Rev        ISSN: 1077-5587            Impact factor:   3.929


  19 in total

1.  Measuring Success in Health Care Value-Based Purchasing Programs: Findings from an Environmental Scan, Literature Review, and Expert Panel Discussions.

Authors:  Cheryl L Damberg; Melony E Sorbero; Susan L Lovejoy; Grant R Martsolf; Laura Raaen; Daniel Mandel
Journal:  Rand Health Q       Date:  2014-12-30

2.  Does the frequency of pay-for-performance payment matter?--Experience from a randomized trial.

Authors:  Sukyung Chung; Latha Palaniappan; Eric Wong; Haya Rubin; Harold Luft
Journal:  Health Serv Res       Date:  2009-12-31       Impact factor: 3.402

Review 3.  Hospital-physician collaboration: landscape of economic integration and impact on clinical integration.

Authors:  Lawton Robert Burns; Ralph W Muller
Journal:  Milbank Q       Date:  2008-09       Impact factor: 4.911

4.  Performance contracting and quality improvement in outpatient treatment: effects on waiting time and length of stay.

Authors:  Maureen T Stewart; Constance M Horgan; Deborah W Garnick; Grant Ritter; A Thomas McLellan
Journal:  J Subst Abuse Treat       Date:  2012-03-23

5.  Patient outcomes and evidence-based medicine in a preferred provider organization setting: a six-year evaluation of a physician pay-for-performance program.

Authors:  Amanda S Gilmore; Yingxu Zhao; Ning Kang; Kira L Ryskina; Antonio P Legorreta; Deborah A Taira; Richard S Chung
Journal:  Health Serv Res       Date:  2007-12       Impact factor: 3.402

6.  Provider and patient directed financial incentives to improve care and outcomes for patients with diabetes.

Authors:  Ilona S Lorincz; Brittany C T Lawson; Judith A Long
Journal:  Curr Diab Rep       Date:  2013-04       Impact factor: 4.810

7.  Physician perception of reimbursement for outpatient procedures among managed care patients with diabetes mellitus.

Authors:  Catherine Kim; Edward F Tierney; William H Herman; Carol M Mangione; K M Venkat Narayan; Robert B Gerzoff; Dori Bilik; Susan L Ettner
Journal:  Am J Manag Care       Date:  2009-01       Impact factor: 2.229

Review 8.  Systematic review: Effects, design choices, and context of pay-for-performance in health care.

Authors:  Pieter Van Herck; Delphine De Smedt; Lieven Annemans; Roy Remmen; Meredith B Rosenthal; Walter Sermeus
Journal:  BMC Health Serv Res       Date:  2010-08-23       Impact factor: 2.655

9.  The impact of expressions of treatment efficacy and out-of-pocket expenses on patient and physician interest in osteoporosis treatment: implications for pay-for-performance programs.

Authors:  Christine A Sinsky; Valerie Foreman-Hoffman; Peter Cram
Journal:  J Gen Intern Med       Date:  2007-12-28       Impact factor: 5.128

10.  Getting real performance out of pay-for-performance.

Authors:  Sean Nicholson; Mark V Pauly; Anita Ya Jung Wu; James F Murray; Steven M Teutsch; Marc L Berger
Journal:  Milbank Q       Date:  2008-09       Impact factor: 4.911

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.